970 filings
Page 37 of 49
8-K
MNKD
MannKind Corporation
4 Nov 13
MannKind Corporation Reports 2013 Third Quarter Financial Results
12:00am
8-K
MNKD
MannKind Corporation
4 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
MNKD
MannKind Corporation
30 Oct 13
MannKind Announces FDA Acknowledgement of Resubmission of New Drug Application for AFREZZA
12:00am
8-K
MNKD
MannKind Corporation
16 Oct 13
Other Events
12:00am
POSASR
MNKD
MannKind Corporation
18 Sep 13
Automatic shelf registration (post-effective amendment)
12:00am
8-K
MNKD
MannKind Corporation
6 Sep 13
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
MNKD
MannKind Corporation
26 Aug 13
Regulation FD Disclosure
12:00am
8-K
MNKD
MannKind Corporation
19 Aug 13
Results of Operations and Financial Condition
12:00am
8-K
MNKD
MannKind Corporation
16 Aug 13
Other Events
12:00am
8-K
MNKD
MannKind Corporation
14 Aug 13
MannKind Reports Positive Data from a Phase 3 Clinical Study of AFREZZA
12:00am
8-K/A
MNKD
MannKind Corporation
14 Aug 13
MannKind Reports Positive Data from a Phase 3 Clinical Study of AFREZZA
12:00am
10-Q
2013 Q2
MNKD
MannKind Corporation
Quarterly report
9 Aug 13
12:00am
S-3ASR
MNKD
MannKind Corporation
19 Jul 13
Automatic shelf registration
12:00am
D
MNKD
MannKind Corporation
15 Jul 13
$178.9M in debt, sold $58.9M, 2 investors
12:00am
8-K
MNKD
MannKind Corporation
1 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K
MNKD
MannKind Corporation
30 May 13
Departure of Directors or Certain Officers
12:00am
S-8
MNKD
MannKind Corporation
23 May 13
Registration of securities for employees
12:00am
10-Q
2013 Q1
MNKD
MannKind Corporation
Quarterly report
10 May 13
12:00am
8-K
MNKD
MannKind Corporation
9 May 13
MannKind Corporation Reports 2013 First Quarter Financial Results
12:00am
DEFA14A
MNKD
MannKind Corporation
12 Apr 13
Additional proxy soliciting materials
12:00am